Quick Comparison
| NAC | Omega-3 (DHA) | |
|---|---|---|
| Half-Life | 5.6 hours | 20-67 hours (plasma), but brain DHA turns over slowly over weeks |
| Typical Dosage | Standard: 600-1800 mg daily in 1-2 divided doses. Clinical (OCD/addiction): 1200-2400 mg daily. Take on an empty stomach for best absorption. Some practitioners combine with Vitamin C to enhance glutathione recycling. | Standard: 1-2 g combined EPA/DHA daily (aim for at least 500 mg DHA). For depression: 1-2 g EPA-dominant fish oil. Triglyceride form is better absorbed than ethyl ester. Take with a fatty meal. |
| Administration | Oral (capsules, powder). Take on an empty stomach. Unpleasant sulfur taste in powder form. | Oral (softgels, liquid). Triglyceride or phospholipid forms preferred over ethyl ester for bioavailability. Take with food containing fat. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
NAC
NAC is deacetylated to cysteine, the rate-limiting substrate for glutathione synthesis via gamma-glutamylcysteine synthetase and glutathione synthetase. Glutathione (GSH) is the primary intracellular antioxidant in neurons, neutralizing reactive oxygen species and maintaining redox balance. NAC also activates the cystine-glutamate antiporter (System Xc-, composed of SLC7A11 and SLC3A2 subunits), which exchanges extracellular cystine for intracellular glutamate in a 1:1 ratio. This non-vesicular mechanism modulates extrasynaptic glutamate levels, reducing NMDA receptor overactivation and excitotoxicity. The glutamate-modulating effect explains NAC's promise in OCD (reducing corticostriatal glutamate hyperactivity), addiction (normalizing nucleus accumbens glutamate after drug exposure), and neurodegenerative conditions involving glutamate dysregulation.
Omega-3 (DHA)
DHA is a structural component of neuronal phospholipids (particularly phosphatidylethanolamine and phosphatidylserine in synaptic membranes), maintaining membrane fluidity which is essential for G-protein-coupled receptor function, ion channel gating, and synaptic vesicle fusion. DHA is metabolized by 15-lipoxygenase to specialized pro-resolving mediators (SPMs) including neuroprotectin D1 (NPD1), which actively resolve neuroinflammation by reducing NF-kappaB activation and pro-inflammatory cytokine production. DHA supports BDNF expression through modulation of the CREB pathway and promotes synaptic plasticity by enhancing long-term potentiation (LTP) and dendritic spine density. It also influences neurotransmitter receptor conformation and binding efficiency. Deficiency impairs membrane signaling, increases neuroinflammation, and accelerates cognitive decline.
Risks & Safety
NAC
Common
Nausea, vomiting, diarrhea, foul-smelling breath.
Serious
May interact with blood thinners and nitroglycerin. Concern that antioxidants may reduce efficacy of chemotherapy (theoretical).
Rare
Bronchospasm (in people with asthma), anaphylactic-like reactions.
Omega-3 (DHA)
Common
Fishy aftertaste, burping, mild gastrointestinal discomfort.
Serious
High doses (>3 g/day) may increase bleeding risk — caution with blood thinners. Fish oil quality matters — choose products tested for mercury and oxidation.
Rare
Allergic reaction in people with fish/shellfish allergy.
Full Profiles
NAC →
N-Acetyl Cysteine is a precursor to glutathione — the body's master antioxidant. In the brain, NAC provides potent neuroprotection against oxidative stress and also modulates glutamate signaling through the cystine-glutamate antiporter. It is used clinically for acetaminophen overdose and is studied for OCD, addiction, and neurodegenerative diseases.
Omega-3 (DHA) →
DHA (docosahexaenoic acid) makes up approximately 40% of the polyunsaturated fatty acids in the brain and is essential for neuronal membrane structure, fluidity, and signaling. DHA deficiency is associated with cognitive decline, depression, and neuroinflammation. It is one of the few supplements with strong evidence for maintaining brain health across the lifespan.